0001309653-24-000002.txt : 20240111 0001309653-24-000002.hdr.sgml : 20240111 20240111160248 ACCESSION NUMBER: 0001309653-24-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240109 FILED AS OF DATE: 20240111 DATE AS OF CHANGE: 20240111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AZAB MOHAMMAD CENTRAL INDEX KEY: 0001309653 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33650 FILM NUMBER: 24529265 MAIL ADDRESS: STREET 1: C/O SUPERGEN, INC. STREET 2: 4140 DUBLIN BLVD., SUITE 200 CITY: DUBLIN STATE: CA ZIP: 94568 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LISATA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0000320017 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 222343568 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 110 ALLEN ROAD STREET 2: SECOND FLOOR CITY: BASKING RIDGE STATE: NJ ZIP: 07920 BUSINESS PHONE: 908-229-2590 MAIL ADDRESS: STREET 1: 110 ALLEN ROAD STREET 2: SECOND FLOOR CITY: BASKING RIDGE STATE: NJ ZIP: 07920 FORMER COMPANY: FORMER CONFORMED NAME: CALADRIUS BIOSCIENCES, INC. DATE OF NAME CHANGE: 20170808 FORMER COMPANY: FORMER CONFORMED NAME: Caladrius Biosciences, Inc. DATE OF NAME CHANGE: 20150608 FORMER COMPANY: FORMER CONFORMED NAME: NeoStem, Inc. DATE OF NAME CHANGE: 20060906 4 1 wk-form4_1705006959.xml FORM 4 X0508 4 2024-01-09 0 0000320017 LISATA THERAPEUTICS, INC. LSTA 0001309653 AZAB MOHAMMAD C/O LISATA THERAPEUTICS, INC, 110 ALLEN ROAD, 2ND FLOOR BASKING RIDGE NJ 07920 1 0 0 0 0 Common Stock 2024-01-09 4 A 0 19480 0 A 58680 D Represents 19,480 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2025. Includes 32,280 unvested restricted stock units. James Nisco, Attorney-in-Fact for Mohammad Azab 2024-01-11